Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Nifty Index Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹102.45 |
| 12 Apr 2015 | ₹145.37 |
| 31 May 2016 | ₹136.31 |
| 19 Jul 2017 | ₹167.44 |
| 07 Sep 2018 | ₹198.16 |
| 27 Oct 2019 | ₹200.18 |
| 15 Dec 2020 | ₹234.60 |
| 03 Feb 2022 | ₹306.11 |
| 25 Mar 2023 | ₹298.58 |
| 12 May 2024 | ₹392.75 |
| 01 Jul 2025 | ₹460.52 |
| 20 Aug 2026 | ₹441.82 |
| Metric | SBI · Direct NAV ₹226.73 Very High risk ★★★☆☆ | Category median Index Funds · 375 funds |
|---|---|---|
| -2.47% | +5.66% | |
| +8.83% | +8.82% | |
| +9.07% | +9.15% | |
| +11.74% | +11.72% | |
| +11.52% | +7.67% | |
| +7.42% | — | |
| +12.78% | +12.67% | |
| +13.08% | +13.64% | |
| +12.81% | +12.84% | |
| Risk | ||
| 13.15% | 13.97% | |
| 0.18 | 0.24 | |
| 0.25 | 0.36 | |
| -38.39% | -16.12% | |
| Nifty 500 | — | |
| -1.84% | +0.84% | |
| 0.86 | 1.00 | |
| 84.6% | 102.2% | |
| 90.0% | 97.2% | |
| 0.24% | 0.36% | |
| ₹13,208Cr | ₹177.09Cr | |
| Up to 0.20% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 71% | 35% | |
| Raviprakash Sharma | — | |
| 02 Jan 2013 | — | |
| 50 | — | |
| 53.4% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.